News – Sound Bioventures

All Fund articles Fund PR Portfolio articles Portfolio PR

AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness

2026.09.302026.09.30 / Financing co-led by Novo Holdings and the Ljungström family office, with participation from the originator Helsinn, existing investors Pureos Bioventures, Sound Bioventures, Industrifonden, Flerie, ...

Alexander Kielland, M.Sc., LL.M., COO

Creating the trust for better, faster venture capital investing

2026.09.302026.09.30 / Alexander Kielland is an experienced VC executive who understands the disruptions and obstacles that global operations face. As COO at Sound Bioventures, he’s committed to ensuring that nothing unnec ...

Breye Therapeutics raises €67.5 million in over-subscribed Series A financing

2026.09.292026.09.29 / Co-led by new investor Mission BioCapital and existing investor Novo Holdings, with additional investment from existing syndicate member Sound Bioventures, and new investors the Ljungström family of ...

Breye - Portfolio Company

Breye Therapeutics has a paper on its oral danegaptide treatment for patients with NPDR published in Science Translational Medicine

2026.09.242026.09.24 / Oral treatment danegaptide represents “a potential paradigm shift” toward earlier, non-invasive treatment of Non-Proliferative Diabetic Retinopathy (NPDR), say authors Study “provides compelling ...

VarmX recognised with two prestigious industry award nominations

2026.09.222026.09.22 / Nominated for the 2026 Prix Galien USA “Best Startup” Award, and shortlisted with partner CSL for “Deal of the Year” at the 2026 European Lifestars Awards Leiden, The Netherlands, 15 Septemb ...

Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34

2026.09.102026.09.10 / · Study shows TT-P34 is safe and well tolerated in healthy volunteers and patients with early-stage Parkinson’s disease (PD), with pharmacokinetics confirming robust CNS exposure · Early ...

Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer

2026.09.082026.09.08 / Dr Ambarkhane brings proven 20+ year track record advancing innovative cancer therapies through clinical development and regulatory approval Appointment strengthens Cytospire's executive leadersh ...

Laura Munck, M.Sc., Analyst

A foundation in science for supporting investments with real-world impact

2026.09.012026.09.01 / For three years, Laura Munck was Student Assistant at Sound Bioventures while also pursuing graduate studies in biomedical sciences at the molecular level. Now, she has the full-time role of Analyst. ...

VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX-C001 in urgent surgery

2026.08.202026.08.20 / • First participant enrolled: EquilibriX-S (NCT07288489), a landmark registrational Phase 3 study of VMX-C001 vs usual pharmacologic care in patients taking FXa inhibitors who require an urgent surge ...

ARTHEx biotech

ARTHEx Biotech Publishes First Demonstration of Improvement in a DM1-related Behavioral Alteration in a Preclinical Model of Myotonic Dystrophy Type 1 (DM1)

2026.07.232026.07.23 / New data show systemic delivery of antimiR-23b developed on Arthex BOOST-ON™ platform reaches the brain, corrects disease biology, and improves behavior—highlighting potential to address CNS manifest ...

Theolytics

Theolytics Relocates to State-of-the-Art Facility at ARC Oxford to Drive Development of THEO-260 and Other Novel Oncolytic Immunotherapies

2026.07.162026.07.16 / Oxford UK, July 14th, 2026. Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, announces that it has relocated to new, state-of-the-art facilitie ...

Simon Mølgaard Named Rising Star in Danish Biotech

2026.06.292026.06.29 / We are proud to congratulate Simon Mølgaard, CEO of our portfolio company Teitur Trophics, on being awarded the Rising Star in Danish Biotech at the Biotech Spring Gala — with the recognition display ...